Analogs of cortistatins, a series of anti-angiogenic compounds isolated from the Indonesian marine sponge Cortisium simplex, were synthesized from estrone by using the Suzuki-Miyaura coupling reaction as the key step. The estrone-isoquinoline hybridized compound showed selective inhibitory activity against the proliferation and VEGF-induced migration of HUVEC.
were almost inactive against KB3-1, Neuro2A, K562 and NHDF cells. Thus, 1a could be a promising selective anti-angiogenic agent. The synthesis of 1a from the steroid, prednisone, has been achieved by Baran's group, 4) and several synthetic studies have been reported. 5, 6) The structure-activity relationship studies of cortistatins 7) have revealed that a) introduction of an oxygen function on the D-ring diminishes the activity, b) the isoquinoline ring is crucial, and c) the dihydroxy group on the A-ring is removable. Taking these observations into account, we designed a simpler compound, namely, estrone-isoquinoline hybrid A (EI-hybrid A, 2). Although the diene system on the BC ring has been reported as likely to be important, 7) 2 could be easily prepared from commercially available estrone, and its bioassay will provide useful information to identify further structure-activity relationships, espe- To whom correspondence should be addressed. Fax: +81-22-717-8785; E-mail: kiyota@biochem.tohoku.ac.jp Abbreviations: dppf, (diphenylphosphino)ferrocene; brsm, based on recovered starting material cially the necessity for the A-and B-rings. In addition, the key coupling reaction between estrone and isoquinoline derivatives could be a model for its total synthesis. We report here the synthesis and biological activities of 2 and some related compounds.
Results and Discussion

Synthesis of EI-hybrid A (2)
For the coupling reaction of the steroidal ring and the isoquinoline, estrone (3) was converted to corresponding stannane 5 * and borate 6 8) via enol triflate 4.
8,9)
Bromoisoquinoline (7) was prepared according to Gensler's procedure as a 2:1 mixture of 7/5-isomers.
10)
The Stille coupling reaction between 5 and 7 did not give any coupling product, so the Suzuki-Miyaura coupling reaction using borate 6 was then examined. Among the palladium catalysts [Pd(PPh 3 ) 4 , Pd(PhCN) 2 Cl 2 , etc.], additives (PPh 3 and AsPh 3 ), bases (KF, CsF, NaOH, Ag 2 O, K 2 CO 3 , Cs 2 CO 3 , etc.) and solvents (DMF, THF, and H 2 O) tested, the combination of Pd(dppf)Cl 2 , Na 2 CO 3 and THF-H 2 O afforded 8 in a 14% yield. When this reaction was carried out under microwave irradiation in DMF-H 2 O, the yield was doubled, and most of starting 6 was recovered. Unexpectedly, the undesired 5 0 -isomer was preferentially formed. A trial of the Stille coupling reaction between triflate 4 and 7-(trimethylstannyl)isoquinoline, as Baran has reported using the corresponding vinyl iodide instead of 4, 4) resulted in the decomposition of both compounds. Hydrogenation of the 16,17-double bond of 8 proceeded stereoselectively on 10% Pd/C for 5 h to give 9. A prolonged reaction time resulted in decomposition of the isoquinoline ring. Finally, deprotection of the TBS group using TBAF afforded EI-hybrid A (2) as a 1:3 mixture of 7 0 /5 0 -isomers. 8 was also treated with TBAF to give Á 16 -EI-hybrid A (10). Since these 7 0 /5 0 -isomers were inseparable, 2 and 10 were subjected to the bioassay in preliminary studies.
Biological activities of the synthetic analogs
The synthetic compounds, EI-hybrid A (2) and Á 16 -EI-hybrid A (10), were tested by several bioassays. Estrone (3) and 7/5-bromoisoquinoline (7) were also included for reference.
EI-Hybrid A (2) selectively inhibited endothelial cell proliferation
To investigate the biological activity of EI-hybrid A (2), we conducted a cell growth inhibition assay for several cell lines, HeLa, SH-SY5Y, NIH3T3, and HUVEC. Cell proliferation was measured by using the WST-8 reagent. 2 selectively inhibited endothelial cell (HUVEC) proliferation (the IC 50 value of 2 was 9.1 mM), but not the proliferation of tumor cells (HeLa and SH-SY5Y) and fibroblast cells (NIH3T3) ( Table 1 ). In contrast, estrone (3), bromoisoquinoline (7), and Á 16 -EIhybrid A (10) did not have any inhibitory effect on each of these cell lines.
EI-Hybrid A (2) inhibited VEGF-induced migration of HUVEC An important step in the development of pathological angiogenesis is thought to involve the signaling pathway of VEGF, a key regulator of malignant tumor growth.
11)
Therefore, we next examined the inhibitory effect of 2 on the VEGF-induced migration of HUVEC for an antiangiogenic effect. In the migration assay, a VEGF treatment significantly induced the migration of HUVEC for 12 h. The induction of migration by VEGF was inhibited by 2 in the range of 3 to 10 mM without significant cell toxicity (Fig. 1) . These results suggest that EI-hybrid A had an anti-angiogenic effect on HUVEC.
EI-Hybrid A (2) did not inhibit the VEGF signaling pathway of HUVEC
It is known that ERK is involved in both the cell growth and migration of endothelial cells. 12) To characterize the effect of 2 on the angiogenesis signaling pathway of HUVEC, we investigated the VEGF-induced phosphorylation of ERK. In a western blotting analysis, ERK was not phosphorylated after 18 h of serum starvation, but was significantly phosphorylated after VEGF addition (Fig. 2 ). 2 did not inhibit VEGF-induced ERK phosphorylation. These results suggest that 2 inhibited a downstream factor of ERK or another pathway concerned with the cells.
Not only was the proliferation of HUVEC cells inhibited by 2 about 10 times more strongly than other cells were, but the migration of HUVEC cells induced by VEGF was also inhibited at the level of 3 mM. Furthermore, 2 did not show inhibitory activity against VEGF-induced ERK phosphorylation. Hence, we hypothesize that its site of action was the downstream factor of ERK, or another pathway for cell migration. Further studies are necessary to clarify the molecular target of 2 (and cortistatins) by using labeled probe compounds or an exhaustive evaluation from a cDNA microarray and proteome analysis. The inactivity of Á 16 -EI-hybrid A (10) indicates that the hydrophobicity of the D-ring as well as the stereochemical angle of isoquinoline-steroid bond of cortistatins were crucial for these activities.
Conclusions
Analogs of cortistatins, a series of anti-angiogenic compounds isolated from the Indonesian marine sponge Cortisium simplex, were synthesized from estrone. The estrone-isoquinoline hybrid (EI-hybrid A, 2) is a candidate for a new anti-angiogenic agent due to its inhibitory activities against the proliferation and migration of HUVEC cells, although the experiments have been carried out only for endothelial cells and the active compound seemed to be the minor 7 0 -isomer contained in 2. More selective synthetic studies of 2 and further analogs, including natural cortistatins, for biological investigation are in progress. (7), and Á 16 -EIhybrid A (10) for 1 h. After VEGF (3.1 ng/ml) stimulation, the cells were incubated for 12 h. After this incubation, the cells that had migrated were counted under a microscope. B, Cell viability was measured by a trypan blue assay. SU5614 was an inhibitor of VEGF receptor activation. 1.15-1.75 (6 H, m), 1.9-2.1 (3 H, m) 0 /7 0 -isomers = 3:1). In the same manner as that described for 10, 9 (50 mg, 0.101 mmol) was converted to 2 (32.0 mg, 83.4 mmol, 82.6%) as a white solid. Cell growth inhibition assay. Cell survival was determined by a WST-8 assay kit (Kishida Kagaku, Osaka, Japan). Briefly, cells (5 Â 10 3 cells/well) in 96-well plates were incubated overnight. The cells were then treated with various concentrations (0, 0.001, 0.01, 0.1, 1, 10, 100 mM) of EI-hybrid A (2), estrone (3), 7/5-bromoisoquinoline (7), and Á 16 -EI-hybrid A (10). After 48 h of incubation, the WST-8 reagents were added to the culture. After 2 h of incubation, the absorbance at 450 nm was measured with a multidetection microplate reader (Dainippon Pharmaceutical, Osaka, Japan). The absorbance was correlated with the number of living cells. The number of living cells (% control) was calculated by the following formula: (each absorbance À absorbance of blank well)/absorbance of 0 mM well Â 100.
Migration assay. The migration assay was performed in a 24-well modified Chemotaxicell chamber (Kurabo, Osaka, Japan). The chamber was placed in a 24-well plate containing 500 ml of HuMedia-EG2 with 0.1% FCS. HUVEC (1 Â 10 5 cells/well) were incubated in the upper chamber for 30 min and treated with or without a chemical compound for 1 h. After VEGF (3.1 ng/ml) stimulation, the cells were allowed to migrate from the upper to the lower chamber for 12 h in 5% CO 2 at 37 C. The non-migratory cells were removed from the upper chamber by wiping the upper surface with a swab. The migrated cells were fixed for 30 min with methanol and stained with hematoxin. After washing with H 2 O, the number of migrated cells was counted in four different fields under a microscope. Cell viability was measured with trypan blue assay. HUVEC were treated with or without a chemical compound for 12 h. After washing with phosphate buffered saline (PBS), the cells were stained with trypan blue. The cell viability (% of control) was calculated by the following formula: (number of total cells À number of dead cells)/number of total cells Â 100.
Western blot analysis. HUVEC (2 Â 10 5 cell/well) were starved with an M199 medium for 18 h and then treated with various concentrations of 2, 3, 7, or 10 for 2 h. After VEGF (3.1 ng/ml) stimulation for 5 min, the cells were lysed with a lysis buffer (20 mM HEPES at pH 7.5, 5 mM EDTA, 150 mM NaCl, 1.5 mM MgCl 2 , 5 mM Na 4 P 2 O 4 , 50 mM NaF, 10% glycerol, 0.2% Triton X-100, 2 mM Na 3 VO 4 , and 1 mM PMSF, a protease inhibitor mixture (complete; Roche Diagnostics). The cell lysate was separated by SDS-PAGE and transferred to a polyvinylidene difluoride membrane (Millipore, Bedford, MA, USA). The membranes was blocked with a 5% non-fat dry milk buffer and probed with specific antibodies. The proteins were visualized with enhanced chemiluminescent substrate detection reagents (Pierce, Rockford, IL, USA).
